NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Moleculin Biotech (MBRX)

Technical Analysis Report for NASDAQ stock MBRX Moleculin Biotech. Dated: 11 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MBRX Moleculin Biotech then click here. or read Experts views on Moleculin Biotech or Forecast & share price targets of Moleculin Biotech

Moleculin Biotech Opened at 2.40 and Closed at: 2.44, which is -1.23% of previous session's close. It moved within a range of 2.40 and 2.50
The session was a Bullish session with an average volume of 134131, which is -382.14% of previous session's volumes.

• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 1 days back on short term averages

Support for tomorrow is 2.42 and resistance for tomorrow is 2.52
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.39, 2.35 resistance for tomorrow's hourly charts is 2.49, 2.55

10 Day SMA for Moleculin Biotech (MBRX) is 2.49 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Moleculin Biotech (MBRX) is 2.5 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Moleculin Biotech (MBRX) is 2.36 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 3.14 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Moleculin Biotech is 2.15 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Moleculin Biotech is at 2.5 and 200 DMA is at 2.15, while 50 DMA and 100 DMA are at 2.36 and 3.14 respectively

Moleculin Biotech (MBRX) moving average of 20 SMA is at 2.5 and 20 EMA is at 2.5

Moleculin Biotech (MBRX) moving average of 50 SMA is at 2.36 and 50 EMA is at 2.58

Moleculin Biotech (MBRX) moving average of 100 SMA is at 3.14 and 100 EMA is at 2.69

Moleculin Biotech (MBRX) moving average of 200 SMA is at 2.15 and 200 EMA is at 2.42

Moleculin Biotech has performed better than Veru Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Pulmatrix Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Macrogenics Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Lipocine Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Lakeland Industries has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Lakeland Industries, about 14.73% more returns!

Kamada has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Kamada, about 0.12% more returns!

Kalvista Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 28.04% more returns!

Moleculin Biotech has performed better than Innoviva Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Inovio Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Inovio Pharmaceuticals, about 19.33% more returns!

Inmune Bio has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Inmune Bio, about 2.27% more returns!

Inogen Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Inogen Inc, about 6.77% more returns!

Evolus Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Evolus Inc, about 36.5% more returns!

Moleculin Biotech has performed better than Editas Medicine in short term. Holding Moleculin Biotech could be a better choice for now!

Edap Tms has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Edap Tms, about 18.47% more returns!

Cue Biopharma has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Cue Biopharma, about 4250% more returns!

Collplant Holdings has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Collplant Holdings, about 21.88% more returns!

Cogentix Medical has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Cogentix Medical, about 12.1% more returns!

Cerus Corporation has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Cerus Corporation, about 25.25% more returns!

Moleculin Biotech has performed better than Arbutus Biopharma in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech Technical analysis of indicators

Price action analysis of Moleculin Biotech (MBRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Moleculin Biotech stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Moleculin Biotech in short term and the sell signal is strong.

Moleculin Biotech Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Moleculin Biotech in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Moleculin Biotech is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.48 and Moleculin Biotech MBRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Moleculin Biotech MBRX stock. Volume based technical analysis of Moleculin Biotech MBRX stock is negative.

Moleculin Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock MBRX Moleculin Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And MBRX Experts View which covers a lot of information including buying and selling signals

MBRX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Moleculin Biotech or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet